Author

Mingchi Ma

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Circulating tumor DNA-based minimal residual disease-guided adjuvant therapy in solid tumors: Current evidence, clinical trial frameworks, and future directions.

The postoperative management of resectable solid tumors depends on clinicopathological risk stratification. However, these static criteria often fail to identify occult minimal residual disease (MRD), resulting in suboptimal adjuvant treatment characterized by either overtreatment or undertreatment. Circulating tumor D...

Ming-Chi Ma, B. Xia, Qian Xu et al. · Chinese journal of cancer re... · 0 citations

Sep 2026

Global burden and inequality of childhood kidney cancer (1990–2050): a systematic analysis for the global burden of disease study 2021

Despite overall declines in the global burden of childhood kidney cancer, substantial disparities persist across sociodemographic contexts, and the importance of improving early diagnosis, access to standardized treatment, and delivery of pediatric oncology care in high-burden settings is emphasized.

Yan-Heng Sun, Qian Xu, Xin Dai et al. · World journal of urology · 0 citations

Aug 2026

Predicting Intratumoral Heterogeneity and Stratifying Prognostic Risk in Gastric Cancer Using a Histology-Based Pathomics-Deep Learning Fusion Model.

A robust and interpretable H&E-based model for predicting MATH-defined ITH and supporting prognostic stratification in patients with GC is developed and may provide a cost-effective and scalable tool to support precision oncology in clinical practice.

Shulun Nie, D. Shi, Shu-Yi Song et al. · Modern Pathology · 0 citations